Free Trial

Hinge Health (HNGE) Stock Price, News & Analysis

Hinge Health logo
$56.66 -1.39 (-2.39%)
As of 02:57 PM Eastern

About Hinge Health Stock (NYSE:HNGE)

Key Stats

Today's Range
$56.24
$59.09
50-Day Range
$34.76
$59.80
52-Week Range
$33.42
$62.00
Volume
290,277 shs
Average Volume
907,418 shs
Market Capitalization
$4.42 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$55.71
Consensus Rating
Buy

Company Overview

Receive HNGE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Hinge Health and its competitors with MarketBeat's FREE daily newsletter.

HNGE Stock News Headlines

New law could create $3.7 trillion tsunami.
During a meeting in Washington D.C., Jeff Brown discovered a bold initiative. He calls it “President Trump’s Project MAFA,” and it could soon return America to a “new” gold standard. The Trump administration, Wall Street, and Silicon Valley are all pushing it forward. The President himself calls the plan “incredible.” Already, it’s helping small plays jump as high as 300%, 318%, 520%, and even 600%.
Hinge Health (NYSE:HNGE) Price Target Raised to $62.00
See More Headlines

HNGE Stock Analysis - Frequently Asked Questions

Hinge Health's stock was trading at $40.15 at the start of the year. Since then, HNGE shares have increased by 42.0% and is now trading at $57.00.

Hinge Health (HNGE) raised $437 million in an IPO on Thursday, May 22nd 2025. The company issued 13,666,000 shares at a price of $32.00 per share.

Hinge Health's quiet period expired on Tuesday, July 1st. Hinge Health had issued 13,666,000 shares in its initial public offering on May 22nd. The total size of the offering was $437,312,000 based on an initial share price of $32.00. During Hinge Health's quiet period, underwriters and any insiders that worked on the IPO were prevented from issuing any research reports for the company because of regulations issued by the Securities and Exchange Commission. Now that the company's quiet period has ended, brokerages that served as underwriters are now able to initiate research on the company.

Hinge Health's top institutional investors include JPMorgan Chase & Co. (1.09%), Franklin Resources Inc. (0.70%), American Century Companies Inc. (0.68%) and Hood River Capital Management LLC (0.64%).

Shares of HNGE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Today
8/14/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
MEDICAL INFO SYS
Sub-Industry
Business Services
Current Symbol
NYSE:HNGE
Previous Symbol
NYSE:HNGE
CIK
1673743
Web
N/A
Fax
N/A
Employees
1,514
Year Founded
N/A

Price Target and Rating

High Price Target
$65.00
Low Price Target
$41.00
Potential Upside/Downside
-4.3%
Consensus Rating
Buy
Rating Score (0-4)
3.06
Research Coverage
16 Analysts

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
78,020,000
Free Float
N/A
Market Cap
$4.54 billion
Optionable
N/A
Beta
N/A

Social Links

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for August 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

This page (NYSE:HNGE) was last updated on 8/14/2025 by MarketBeat.com Staff
From Our Partners